103 results on '"Parente A"'
Search Results
2. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer
3. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
4. EP08.04-002 Australian Vinorelbine Use in Advanced Lung cancer (The AVAL Study)
5. EP05.03-006 Real-World Treatment Pathways In Stage III Non-Small Cell Lung Cancer in Portugal (PICTuRE): An Interim Analysis Of Surgical Patients
6. EP14.05-016 Patterns of Care for Small Cell Lung Cancer in Victoria Australia. A Prospective Population-Based Observational Study
7. EP08.01-065 Prevalence of Non-driver Mutations and Characterization of Patients with Advanced or Metastatic Non-small Cell Lung Cancer
8. EP04.01-011 Diagnostic Approach and Treatment of Lung Cancer Patients in Portugal: Portuguese Lung Cancer Study Group Survey
9. EP03.01-009 BrainMets-Cross-Sectional Study To Identify The Presence Of Brain Metastasis At Diagnosis Of Advanced NSCLC EGFRm in Portuguese Patients
10. EP08.01-065 Prevalence of Non-driver Mutations and Characterization of Patients with Advanced or Metastatic Non-small Cell Lung Cancer
11. EP05.03-006 Real-World Treatment Pathways In Stage III Non-Small Cell Lung Cancer in Portugal (PICTuRE): An Interim Analysis Of Surgical Patients
12. EP03.01-009 BrainMets-Cross-Sectional Study To Identify The Presence Of Brain Metastasis At Diagnosis Of Advanced NSCLC EGFRm in Portuguese Patients
13. The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
14. The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification
15. EP04.01-011 Diagnostic Approach and Treatment of Lung Cancer Patients in Portugal: Portuguese Lung Cancer Study Group Survey
16. EP14.05-016 Patterns of Care for Small Cell Lung Cancer in Victoria Australia. A Prospective Population-Based Observational Study
17. EP08.04-002 Australian Vinorelbine Use in Advanced Lung cancer (The AVAL Study)
18. Alpha-1 Antitrypsin Deficiency and Lung Cancer Risk: A Case–Control Study in Never-Smokers
19. P52.06 “High Tumor Burden” in Metastatic Non-Small Cell Lung Cancer: Defining the Concept
20. OA05.06 Lessons Learned from the Victorian Lung Cancer Registry: Opportunities for Quality Improvement in Lung Cancer Management and Outcomes
21. P09.02 Impact of COVID-19 in Portuguese Lung Cancer Patients’ Treatment: Portuguese Lung Cancer Study Group Survey
22. P09.02 Impact of COVID-19 in Portuguese Lung Cancer Patients’ Treatment: Portuguese Lung Cancer Study Group Survey
23. P52.06 'High Tumor Burden' in Metastatic Non-Small Cell Lung Cancer: Defining the Concept
24. Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
25. OA05.06 Lessons Learned from the Victorian Lung Cancer Registry: Opportunities for Quality Improvement in Lung Cancer Management and Outcomes
26. The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification
27. P2.10-05 Indoor Radon and Lung Cancer Risk. A Pooling Study on the Second Risk Factor for Lung Cancer
28. OA09.06 Residential Radon, Smoking and Lung Cancer Risk. A Case-Control Study in a Radon Prone Area
29. OA09.06 Residential Radon, Smoking and Lung Cancer Risk. A Case-Control Study in a Radon Prone Area
30. P2.10-05 Indoor Radon and Lung Cancer Risk. A Pooling Study on the Second Risk Factor for Lung Cancer
31. The International Association for the Study of Lung Cancer Lung Cancer Staging Project : proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer
32. Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
33. P1.01-002 Environmental Tobacco Smoke Exposure and EGFR Mutations/ALK Translocation in Never Smokers. A Multicenter Study in Spanish Never-Smokers
34. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer
35. P1.01-002 Environmental Tobacco Smoke Exposure and EGFR Mutations/ALK Translocation in Never Smokers. A Multicenter Study in Spanish Never-Smokers
36. The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer
37. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
38. P1-026: Computer tomographic-guided transthoracic needle aspiration biopsy in the diagnosis of intra-thoracic malignant disease – 5 years in review
39. P2-295: Phase II trial a 2-h infusion of Gemcitabine-carboplatin combination as first-line therapy for stage IIIB or IV non-small cell lung cancer
40. P1-175: Bronchioloalveolar Lung Carcinoma – the new histological classification – Surgically approached cases – 5 years in review
41. P1-175: Bronchioloalveolar Lung Carcinoma – the new histological classification – Surgically approached cases – 5 years in review
42. P1-026: Computer tomographic-guided transthoracic needle aspiration biopsy in the diagnosis of intra-thoracic malignant disease – 5 years in review
43. P2-226: The Portuguese experience with pemetrexed (ALIMTA) in second line treatment of non-small cell lung cancer
44. : P2-235: Optimal duration of chemotherapy in non-small-cell lung cancer: multicenter, randomized, prospective clinical trial comparing 4 vs 6 cycles of carboplatin and gemcitabine
45. P2-295: Phase II trial a 2-h infusion of Gemcitabine-carboplatin combination as first-line therapy for stage IIIB or IV non-small cell lung cancer
46. P3-111: Cutaneous side–effects of erlotinib treatment in lung cancer patients
47. P2-235: Optimal duration of chemotherapy in non-small-cell lung cancer: multicenter, randomized, prospective clinical trial comparing 4 vs 6 cycles of carboplatin and gemcitabine
48. P2-226: The Portuguese experience with pemetrexed (ALIMTA) in second line treatment of non-small cell lung cancer
49. P3-111: Cutaneous side–effects of erlotinib treatment in lung cancer patients
50. Alpha-1 Antitrypsin Deficiency and Lung Cancer Risk A Case-Control Study in Never-Smokers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.